(Q45986635)

18 December 2017

title

Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. (English)

1 reference

18 December 2017

author

Randy J. Seeley

3

1 reference

18 December 2017

author name string

Tammy L Kindel

1

1 reference

18 December 2017

Stephanie M Yoder

2

1 reference

18 December 2017

David A D'Alessio

4

1 reference

18 December 2017

Patrick Tso

5

1 reference

18 December 2017

publication date

12 May 2009

1 reference

18 December 2017

Journal of Gastrointestinal Surgery

published in

1 reference

18 December 2017

volume

13

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

1762-1772

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s11605-009-0912-9

exact match

0 references

cites work

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11605-009-0912-9

Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes

21 January 2018

1 reference

12 December 2020

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

12 December 2020

Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats

1 reference

12 December 2020

Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice

1 reference

12 December 2020

Etiology of type II diabetes mellitus: role of the foregut

1 reference

12 December 2020

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

1 reference

12 December 2020

Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats

1 reference

12 December 2020

Type 2 diabetes - a matter of failing beta-cell neogenesis? Clues from the GK rat model.

1 reference

12 December 2020

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

1 reference

12 December 2020

Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion

1 reference

12 December 2020

How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number

1 reference

12 December 2020

Remission of diabetes after laparoscopic gastric bypass

1 reference

12 December 2020

Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.

1 reference

12 December 2020

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

1 reference

12 December 2020

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

12 December 2020

GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans

1 reference

12 December 2020

Production of spontaneous diabetic rats by repetition of selective breeding

1 reference

12 December 2020

Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.

1 reference

12 December 2020

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

12 December 2020

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

1 reference

12 December 2020

The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice

1 reference

12 December 2020

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

1 reference

12 December 2020

Long-term changes in weight loss and obesity-related comorbidities after Roux-en-Y gastric bypass: a primary care experience

1 reference

12 December 2020

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

1 reference

12 December 2020

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

1 reference

12 December 2020

The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action

1 reference

12 December 2020

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

1 reference

12 December 2020

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

12 December 2020

Glucagon-like peptide-1 is a physiological incretin in rat

1 reference

12 December 2020

Impaired insulin secretion in the spontaneous diabetes rats

1 reference

12 December 2020

Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes

1 reference

12 December 2020

Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1

1 reference

12 December 2020

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.

1 reference

12 December 2020

Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery

1 reference

12 December 2020

Mechanism for improved insulin sensitivity after gastric bypass surgery

1 reference

12 December 2020

Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects

1 reference

12 December 2020

Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide

1 reference

12 December 2020

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

1 reference

12 December 2020

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

1 reference

12 December 2020

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

1 reference

12 December 2020

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

1 reference

12 December 2020

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

1 reference

12 December 2020

Procedure incidence and in-hospital complication rates of bariatric surgery in the United States.

1 reference

12 December 2020

Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

1 reference

12 December 2020

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

1 reference

12 December 2020

Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.

1 reference

12 December 2020

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

12 December 2020

Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass

1 reference

12 December 2020

Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus.

1 reference

12 December 2020

The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.

1 reference

12 December 2020

Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat

1 reference

12 December 2020

Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet

1 reference

12 December 2020

Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures

1 reference

12 December 2020

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

1 reference

12 December 2020

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

12 December 2020

The effects of ileal transposition on food intake and body weight loss in VMH-obese rats

1 reference

12 December 2020

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

12 December 2020

10.1007/S11605-009-0912-9

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

0 references

1 reference

18 December 2017